![RSV positivity associated with reduced serious bacterial infection risk [Classics Series]](https://www.2minutemedicine.com/wp-content/uploads/2013/09/800px-Respiratory_syncytial_virus_01-350x250.jpg)
Shionogi and UBE: Novel Antiviral Drug Demonstrates Efficacy in RSV Patients
RSV patients treated with antiviral drug S-337395 showed statistically significant reduction in viral load S-337395 is generally safe and well...
Aurion Biotech: Cell Therapy AURN001 Improves Vision in Patients with Corneal Endothelial Disease
AURN001 demonstrates improvement of visual acuity in patients with corneal endothelial dysfunction. The CLARA trial demonstrates favorable safety profiles across...
Novocure: Wearable Electric Therapy Increases Survival in Patients with Pancreatic Adenocarcinoma
Tumor Treating Fields therapy demonstrates increased overall survival in patients with unresectable pancreatic cancer. The novel therapy was safe and...
Intellia Therapeutics: NTLA-2002 CRISPR-based therapy reduces rates of Hereditary Angioedema (HAE) attacks
CRISPR gene editing based treatment reduced HAE attacks rates by up to 80%. NTLA-2002 was well tolerated by patients. The...
Aligos Therapeutics: ALG-055009 reduces liver fatty deposits in patients with metabolic-dysfunction associated steatohepatitis (MASH)
ALG-055009, a thyroid hormone receptor agonist, significantly reduced liver fat in patients with MASH after 12 weeks of treatment. ALG-055009...
GSK: Depemokimab Monoclonal Antibody Reduces Asthma Attacks
Depemokimab was shown to reduce exacerbations in patients with severe asthma. The proportions of adverse events of Depemokimab and the...
Levicept: LEVI-04 Reduces Osteoarthritis Pain
Patients with chronic pain from osteoarthritis who received LEVI-04 had a 50% reduction in pain from baseline. LEVI-04 was well...
uniQure: AMT-130 Gene Therapy Slows Progression of Huntington’s Disease
A dose-dependent slowing in Huntington's disease progression was observed after 24 months in patients receiving high-dose AMT-130. The gene therapy...
Altimmune: GLP-1/Glucagon Receptor Agonist Pemvidutide Preserves Lean Mass During Weight Loss
Patients on pemvidutide experienced only 21.9% of weight loss attributable to lean mass. Pemvidutide preserves muscle tissue and prioritizes fat...
Arrowhead Pharmaceuticals: RNA interference Medication Plozasiran Lowers Triglycerides in Dyslipidemia
Patients with familial chylomicronemia syndrome (FCS) treated with plozasiran demonstrated a maximum reduction of 98% in triglyceride levels at month...